TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
8,023
|
5,094
|
6,060 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
6,425
|
3,204
|
5,569 |
| EBITDA |
5,779
|
2,673
|
5,564 |
| Total assets |
38,582
|
33,387
|
31,810 |
| Current assets |
22,513
|
23,318
|
21,740 |
| Current liabilities |
1,485
|
778
|
907 |
| Equity capital |
35,288
|
30,952
|
29,348 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.5%
|
92.7%
|
92.3% |
| Turnover per employee |
4,012
|
2,547
|
3,030 |
| Profit as a percentage of turnover |
80.1%
|
62.9%
|
91.9% |
| Return on assets (ROA) |
16.7%
|
9.6%
|
17.5% |
| Current ratio |
1516.0%
|
2997.2%
|
2396.9% |
| Return on equity (ROE) |
18.2%
|
10.4%
|
19.0% |
| Change turnover |
2,929
|
-966
|
1,042 |
| Change turnover % |
57%
|
-16%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.